Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00953173 · ClinicalTrials.gov registry record
HERO Study: Helping Evaluate Reduction in Obesity
A clinical trial of Obesity, sponsored by Apollo Endosurgery.
- Completed
- Registry status
- 671
- Enrollment target
- 6
- Study locations
NCT00953173: Completed study of Obesity, sponsored by Apollo Endosurgery.
NCT00953173 is a study of Obesity that has completed, run by Apollo Endosurgery. The registered enrollment target is 671 participants, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (18% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00953173, a study of Obesity, has completed, sponsored by Apollo Endosurgery.
- COMPLETED
- Registry status
- 671 participants
- Enrollment target
- 6
- Study locations
Study Summary
A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.
Conditions Studied
Interventions
- DEVICE LAP-BAND AP® Adjustable Gastric Banding System
Study Locations (6)
Other
- - Jette
- - Naples
- - Birmingham
Washington
- - Everett
South Australia
- - Adelaide
Ontario
- - Mississauga
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 671 participants |
| Start Date | 2009-12 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00953173
The ClinicalTrials.gov registry entry for NCT00953173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 671 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (18% lower). The listed sponsor is Apollo Endosurgery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which LAP-BAND AP® Adjustable Gastric Banding System is the first listed.
NCT00953173 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Other, Washington, South Australia.
Frequently Asked Questions
What is clinical trial NCT00953173 about?
NCT00953173 is a clinical study titled "HERO Study: Helping Evaluate Reduction in Obesity". A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.
What is the current status of trial NCT00953173?
This trial is currently completed. The enrollment target is 671 participants. The study started on 2009-12. Estimated completion is 2016-10.
What conditions does trial NCT00953173 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT00953173?
The interventions under investigation include: LAP-BAND AP® Adjustable Gastric Banding System (DEVICE).
Who is sponsoring clinical trial NCT00953173?
This trial is sponsored by Apollo Endosurgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00953173 being conducted?
This trial has 6 study locations across Washington, South Australia, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.